Stockholders Equity and StockBased Compensation (Tables)

6 Months Ended

Jun. 30, 2025

Stockholders Equity and StockBased Compensation

Schedule Of stock option

		Number of Options				Weighted Average Exercise Price				Weighted-Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding, December 31, 2024			464,940			$	16.24				3.07			$	184,818
Granted			10,448				9.42								—
Exercised			(99,714	)			6.35								725,882
Forfeited			—				—								—
Expired			(15,233	)			75.60								—
Outstanding, June 30, 2025			360,441			$	16.27				2.25				1,215,405
Vested and expected to vest, end of the period			360,441			$	16.27				2.25				1,215,405
Options exercisable, end of the period			340,776			$	17.02				1.88			$	1,016,618

Schedule Of Share-based Compensation, Stock Options, Activity

		Six Months Ended
		June 30,
		2025				2024
Expected volatility			117.44	%			75.36	%
Risk free interest rate			3.95	%			4.54	%
Dividend yield rate			—				—
Expected life			2 years				2 years
Closing price per share - common stock		$	9.42			$	2.62

Schedule Of outstanding RSA

		Number of Shares				Weighted- Average Grant Date Fair Value				Aggregate Fair Value
Outstanding, December 31, 2024			781,864			$	5.19			$	3,698,217
Awards granted			357,940				7.26				2,597,022
Awards vested			(122,283	)			5.81				1,039,505
Awards forfeited			—				—				—
Outstanding, June 30, 2025			1,017,521			$	5.84			$	13,604,256

Schedule of stock based compensation expense

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2025				2024				2025				2024
Research and development expenses		$	0.2			$	0.1			$	0.4			$	0.1
General and administrative expenses			0.5				0.3				1.6				0.7
Total stock-based compensation expense		$	0.7			$	0.4			$	2.0			$	0.8